BACKGROUND: Lateral epicondylitis (LE)1 affects between 1 and 3% of the population. Recently, platelet-rich plasma (PRP)2 has gained popularity. AIM: Assess the long-term outcomes of PRP for patients with refractory LE. METHODS: We assessed 31 patients who had failed conservative management using the Oxford Elbow Score (OES).3. RESULTS: Mean follow-up: 5.2 years (range 4.2-6.1 years).87.1% exhibited minimum clinically important difference (MCID)4 in pain scores between pre-op and long-term. 90.3% displayed MCID in function and psycho-social domains.Two patients had a repeat injection and six underwent open release. DISCUSSION: PRP is successful in treating refractory LE in most patients and avoiding surgery.
BACKGROUND: Lateral epicondylitis (LE)1 affects between 1 and 3% of the population. Recently, platelet-rich plasma (PRP)2 has gained popularity. AIM: Assess the long-term outcomes of PRP for patients with refractory LE. METHODS: We assessed 31 patients who had failed conservative management using the Oxford Elbow Score (OES).3. RESULTS: Mean follow-up: 5.2 years (range 4.2-6.1 years).87.1% exhibited minimum clinically important difference (MCID)4 in pain scores between pre-op and long-term. 90.3% displayed MCID in function and psycho-social domains.Two patients had a repeat injection and six underwent open release. DISCUSSION: PRP is successful in treating refractory LE in most patients and avoiding surgery.
Authors: Nikolas Baksh; Charles P Hannon; Christopher D Murawski; Niall A Smyth; John G Kennedy Journal: Arthroscopy Date: 2013-01-24 Impact factor: 4.772
Authors: Allan K Mishra; Nebojsa V Skrepnik; Scott G Edwards; Grant L Jones; Steven Sampson; Doug A Vermillion; Matthew L Ramsey; David C Karli; Arthur C Rettig Journal: Am J Sports Med Date: 2013-07-03 Impact factor: 6.202
Authors: Seyed Ahmad Raeissadat; Leyla Sedighipour; Seyed Mansoor Rayegani; Mohammad Hasan Bahrami; Masume Bayat; Rosa Rahimi Journal: Pain Res Treat Date: 2014-01-20